Bosh sahifaIDXX • NASDAQ
IDEXX Laboratories, Inc.
417,24 $
Seans yopilganidan keyin:
417,24 $
(0,00%)0,00
Yopilgan:22-noy, 16:20:00 (GMT-5) · USD · NASDAQ · Ogohlantirish
AksiyalarAQSH qimmatli qogʻoziBosh shtabi: AQSH
Yopilish kursi
418,55 $
Kunlik diapazon
415,80 $ - 422,98 $
Yillik diapazon
398,50 $ - 583,39 $
Bozor kapitalizatsiyasi
34,17 mlrd USD
Oʻrtacha hajm
741,32 ming
Narx/foyda
40,26
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(USD)sen, 2024Y/Y qiyosi
Daromad
975,54 mln6,56%
Joriy xarajat
230,65 mln-15,42%
Sof foyda
232,84 mln9,71%
Sof foyda marjasi
23,872,98%
Har bir ulushga tushum
2,8010,67%
EBITDA
399,52 mln31,31%
Amaldagi soliq stavkasi
22,10%
Jami aktivlari
Jami passivlari
(USD)sen, 2024Y/Y qiyosi
Naqd pul va qisqa investitsiyalar
308,64 mln-6,95%
Jami aktivlari
3,35 mlrd8,57%
Jami passivlari
1,73 mlrd-3,15%
Umumiy kapital
1,62 mlrd
Tarqatilgan aksiyalar
81,88 mln
Narxi/balansdagi bahosi
21,22
Aktivlardan daromad
27,00%
Kapitaldan daromad
34,70%
Naqd pulning sof oʻzgarishi
(USD)sen, 2024Y/Y qiyosi
Sof foyda
232,84 mln9,71%
Operatsiyalardan naqd pul
220,08 mln-19,22%
Sarmoyadan naqd pul
-27,37 mln1,69%
Moliyadan naqd pul
-290,98 mln-576,10%
Naqd pulning sof oʻzgarishi
-92,95 mln-146,74%
Boʻsh pul
210,00 mln7,40%
Haqida
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses. In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO. Wikipedia
Tashkil etilgan
19-dek, 1983
Xodimlar soni
11 000
Yana
Bu sizni qiziqtirishi mumkin
Bu roʻyxat oxirgi qidiruvlar, kuzatilgan aksiyalar va boshqa faoliyatdan tuzilgan. Batafsil

Barcha axborotlar faqat maʼlumot sifatida “shundayligicha” taqdim etilgan, ulardan moliyaviy maslahat sifatida foydalanmang, ular savdo maqsadlari yoki investitsiya, soliq, yuridik, buxgalteriya yoki boshqa turdagi maslahat emas. Google investitsiya borasida maslahatchi emas, bu roʻyxatdagi kompaniyalar yoki ularning aksiyalari borasida hech qanday nuqtai nazar, tavsiya yoki fikr bildirmaydi. Har qanday savdoni boshlashdan oldin broker yoki moliyaviy vakil bilan maslahatlashib, narxlarni tekshiring. Batafsil
Aloqador qidiruvlar
Qidiruv
Qidiruv maydonini tozalash
Qidiruvni yopish
Google ilovalari
Asosiy menyu